The response of plasma catecholamines to intravenous labetalol: A comparison with sodium nitroprusside
- 1 October 1983
- journal article
- research article
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 34 (4) , 466-473
- https://doi.org/10.1038/clpt.1983.199
Abstract
Changes in mean arterial pressure (MAP), heart rate (HR) and plasma concentrations of norepinephrine (NE) and epinephrine were measured in 8 hypertensive patients in a supine position after stepwise infusion of incremental sodium nitroprusside doses and i.v. injection of cumulative labetalol doses. Both drugs induced rises in plasma NE concentration that were linearly related to reductions in MAP. For any reduction in blood pressure (BP), the rise in plasma NE concentration induced by labetalol was approximately 4 times that induced by sodium nitroprusside. The difference can be explained by 2 effects of labetalol: impairment of neuronal NE uptake and .beta.-adrenergic-receptor blockade, which are known to reduce NE clearance from plasma. After both drugs there was a correlation between changes in HR and changes in BP and a correlation between changes in HR and changes in plasma NE concentration. Slope of the regression lines for both relationships were less after labetalol than after sodium nitroprusside, presumably because of the .beta.-adrenergic-blocking preperties of labetalol. Multiple-regression analysis indicated that the plasma NE rise was an important determinant of the vasodepressor response to each drug. The greater plasma NE elevation after labetalol may limit its antihypertensive effect.This publication has 22 references indexed in Scilit:
- Labetalol: Bioavailability, Drug Plasma Levels, Plasma Renin and Catecholamines in Acute and Chronic Treatment of Resistant HypertensionAustralian and New Zealand Journal of Medicine, 1978
- Changes in plasma noradrenaline concentration following sympathetic stimulation by gradual tiltingCardiovascular Research, 1978
- Effect of labetalol on plasma noradrenaline and adrenaline in hypertensive manEuropean Journal of Clinical Pharmacology, 1978
- The effects of labetalol (AH 5158) on metabolism of 3H(−)-noradrenaline released from the cat spleen by nerve stimulationBiochemical Pharmacology, 1977
- Simultaneous single isotope radioenzymatic assay of plasma norepinephrine, epinephrine and dopamineLife Sciences, 1977
- Regulation of norepinephrine release from cardiac sympathetic fibers in the dog by presynaptic alpha- and beta-receptors.Circulation Research, 1977
- Hemodynamic effects of labetalol, an alpha and beta adrenergic blocking agent, in hypertensive subjects.Circulation, 1977
- Use of plasma norepinephrine for evaluation of sympathetic neuronal function in manLife Sciences, 1976
- Control of the Splanchnic Circulation in ManCirculation Research, 1967
- New Tables for Multiple Comparisons with a ControlPublished by JSTOR ,1964